ACE2 and COVID-19: In this study, 19% of subjects were coincidently abnormal using low stringency cutoffs for blood cell ACE2 expression, TIMP-1, PIIINP and MMP-9, a 5-fold enrichment for theoretical risk of PCC among those hospitalized for COVID19.